Type your tag names separated by a space and hit enter

    Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure--United States, 2016.

    Abstract

    CDC has updated its interim guidance for U.S. health care providers caring for women of reproductive age with possible Zika virus exposure to include recommendations on counseling women and men with possible Zika virus exposure who are interested in conceiving. This guidance is based on limited available data on persistence of Zika virus RNA in blood and semen. Women who have Zika virus disease should wait at least 8 weeks after symptom onset to attempt conception, and men with Zika virus disease should wait at least 6 months after symptom onset to attempt conception. Women and men with possible exposure to Zika virus but without clinical illness consistent with Zika virus disease should wait at least 8 weeks after exposure to attempt conception. Possible exposure to Zika virus is defined as travel to or residence in an area of active Zika virus transmission ( http://www.cdc.gov/zika/geo/active-countries.html), or sex (vaginal intercourse, anal intercourse, or fellatio) without a condom with a man who traveled to or resided in an area of active transmission. Women and men who reside in areas of active Zika virus transmission should talk with their health care provider about attempting conception. This guidance also provides updated recommendations on testing of pregnant women with possible Zika virus exposure. These recommendations will be updated when additional data become available.

    Links

  • FREE Publisher Full Text

    • Grapherence [↓24]

    Authors

    Petersen EE
    ,
    Polen KN
    ,
    Meaney-Delman D
    ,
    Ellington SR
    ,
    Oduyebo T
    ,
    Cohn A
    ,
    Oster AM
    ,
    Russell K
    ,
    Kawwass JF
    ,
    Karwowski MP
    ,
    Powers AM
    ,
    Bertolli J
    ,
    Brooks JT
    ,
    Kissin D
    ,
    Villanueva J
    ,
    Muñoz-Jordan J
    ,
    Kuehnert M
    ,
    Olson CK
    ,
    Honein MA
    ,
    Rivera M
    ,
    Jamieson DJ
    ,
    Rasmussen SA

    Source

    MeSH

    Adolescent
    Adult
    Centers for Disease Control and Prevention (U.S.)
    Diagnostic Tests, Routine
    Directive Counseling
    Disease Outbreaks
    Female
    Health Personnel
    Humans
    Infertility, Female
    Male
    Mass Screening
    Practice Guidelines as Topic
    Preconception Care
    Pregnancy
    Pregnancy Complications, Infectious
    Residence Characteristics
    Travel
    United States
    Young Adult
    Zika Virus Infection

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    27031943

    Citation

    Petersen, Emily E., et al. "Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age With Possible Zika Virus Exposure--United States, 2016." MMWR. Morbidity and Mortality Weekly Report, vol. 65, no. 12, 2016, pp. 315-22.
    Petersen EE, Polen KN, Meaney-Delman D, et al. Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure--United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(12):315-22.
    Petersen, E. E., Polen, K. N., Meaney-Delman, D., Ellington, S. R., Oduyebo, T., Cohn, A., ... Rasmussen, S. A. (2016). Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure--United States, 2016. MMWR. Morbidity and Mortality Weekly Report, 65(12), pp. 315-22. doi:10.15585/mmwr.mm6512e2.
    Petersen EE, et al. Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age With Possible Zika Virus Exposure--United States, 2016. MMWR Morb Mortal Wkly Rep. 2016 Apr 1;65(12):315-22. PubMed PMID: 27031943.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure--United States, 2016. AU - Petersen,Emily E, AU - Polen,Kara N D, AU - Meaney-Delman,Dana, AU - Ellington,Sascha R, AU - Oduyebo,Titilope, AU - Cohn,Amanda, AU - Oster,Alexandra M, AU - Russell,Kate, AU - Kawwass,Jennifer F, AU - Karwowski,Mateusz P, AU - Powers,Ann M, AU - Bertolli,Jeanne, AU - Brooks,John T, AU - Kissin,Dmitry, AU - Villanueva,Julie, AU - Muñoz-Jordan,Jorge, AU - Kuehnert,Matthew, AU - Olson,Christine K, AU - Honein,Margaret A, AU - Rivera,Maria, AU - Jamieson,Denise J, AU - Rasmussen,Sonja A, Y1 - 2016/04/01/ PY - 2016/4/1/entrez PY - 2016/4/1/pubmed PY - 2016/8/5/medline SP - 315 EP - 22 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb. Mortal. Wkly. Rep. VL - 65 IS - 12 N2 - CDC has updated its interim guidance for U.S. health care providers caring for women of reproductive age with possible Zika virus exposure to include recommendations on counseling women and men with possible Zika virus exposure who are interested in conceiving. This guidance is based on limited available data on persistence of Zika virus RNA in blood and semen. Women who have Zika virus disease should wait at least 8 weeks after symptom onset to attempt conception, and men with Zika virus disease should wait at least 6 months after symptom onset to attempt conception. Women and men with possible exposure to Zika virus but without clinical illness consistent with Zika virus disease should wait at least 8 weeks after exposure to attempt conception. Possible exposure to Zika virus is defined as travel to or residence in an area of active Zika virus transmission ( http://www.cdc.gov/zika/geo/active-countries.html), or sex (vaginal intercourse, anal intercourse, or fellatio) without a condom with a man who traveled to or resided in an area of active transmission. Women and men who reside in areas of active Zika virus transmission should talk with their health care provider about attempting conception. This guidance also provides updated recommendations on testing of pregnant women with possible Zika virus exposure. These recommendations will be updated when additional data become available. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/27031943/full_citation L2 - https://dx.doi.org/10.15585/mmwr.mm6512e2 DB - PRIME DP - Unbound Medicine ER -